Corbus Pharmaceuticals Holdings Inc. Stock Slides 14.4%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. tumbled 14.4% to $6.92 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.8% to 25,981.57 and Dow Jones Industrial Average falling 0.6% to 52,093.11.

This was the stock's eighth consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 66.3% short of its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 3.1% to $4.99, Fortress Biotech Inc. fell 1.6% to $2.49, and Viking Therapeutics Inc. fell 5.01% to $29.95.

Trading volume totaled 3.7 million, compared to the 50-day average of 633,169.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 15, 2026 16:33 ET (20:33 GMT)